Broad Institute
Peixin Zhu is an accomplished scientist and executive with extensive experience in the fields of gene therapy and neuroscience. Currently serving as VP of Editing Discovery at Verve Therapeutics and an Affiliate Member at both the Broad Institute of MIT and Harvard and the National Institute of Genetics in Japan, Peixin Zhu has a strong background in innovative research, including significant leadership roles at Tevard Biosciences and LogicBio Therapeutics. Peixin Zhu's earlier career included positions at Exegenesis Bio Inc. and AGTC, focusing on advanced gene therapy techniques and AAV platform developments. With a Ph.D. in Neuropharmacology from Heidelberg University and additional degrees in Molecular Biology and General Biology, Peixin Zhu is well-equipped with a blend of academic and practical expertise in cutting-edge biotechnologies.
This person is not in any teams
This person is not in any offices
Broad Institute
2 followers
The Eli and Edythe L. Broad Institute of MIT and Harvard, often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States.